Navigation Links
Immune Cells Shrink Tumors in Mice
Date:2/13/2009

They target a protein found in some cancers, study finds

FRIDAY, Feb. 13 (HealthDay News) -- Scientists say certain tumors in mice have shrunk or disappeared after the animals were injected with genetically engineered immune system cells that target a protein found in certain human cancers.

The lab-altered T-cells zeroed in on mesothelin, a still mysterious protein produced in abundance by all pancreatic cancers and mesotheliomas, as well as many ovarian and non-small-cell lung cancers. The protein is believed to play a role in the spread and growth of cancer cells, a theory backed by past animal and human studies that found attacking mesothelin can shrink tumors.

"Based on the size of the tumors and the number of cells administered, we estimate that one mesothelin-targeted T-cell was able to kill about 40 tumor cells," study leader Dr. Carl H. June, a professor of pathology and laboratory medicine at the University of Pennsylvania School of Medicine, said in a news release issued by the school and its partner in the research, the U.S. National Institutes of Health. "This finding indicates that small doses of these cells may have potential in treating patients with large tumors."

According to the study, published in this week's online issue of the Proceedings of the National Academy of Sciences, the altered T-cells secrete proteins attracted to mesothelin. Once bound to the mesothelin, the T-cells fighting ability shifts into overdrive, producing multiple cytokines that boost the immune system. Other proteins are released by the T-cells to make them less susceptible to tumor's defenses.

The researchers tested the new T-cells on mice with tumors that developed from the implantation of human mesothelioma cells in their skin. When the T-cells were injected into tumors or into the veins of the mice, the tumors disappeared or shrank.

"Mesothelin is a promising candidate for generating tumor-targeting T-cells, given its limited expression in normal tissues and high expression in several cancers," study collaborator Dr. Ira Pastan, chief of the molecular biology laboratory of the U.S. National Cancer Institute's Center for Cancer Research, said in the news release.

Clinical trials that would use the altered T-cells in patients with mesothelioma and ovarian cancer are in the works, June said.

More information

The U.S. National Cancer Institute has more about mesothelioma.



-- Kevin McKeever



SOURCE: U.S. National Institutes of Health/University of Pennsylvania, news release, Feb. 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. Immune deficiency linked to a type of eye cancer
3. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
4. Melanoma drug revs immune cells but cancer cells ignore it
5. Study identifies key player in the bodys immune response to chronic stress
6. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
7. UVA researchers find important clue to immune infertility
8. M.D. Anderson-led team reports possible key to autoimmune disease
9. Their immune cells, fighting your cancer
10. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
11. Occupational exposures may be linked to death from autoimmune disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune Cells Shrink Tumors in Mice
(Date:8/21/2017)... ... 2017 , ... The American Hospital Association (AHA) has elected Claire Zangerle, Chief ... its Board of Trustees for a three-year term beginning January 1, 2018. , ... individuals that are committed to the improvement of health in their communities. Founded in ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership commitment to ... stress disorder (PTSD) and traumatic brain injuries (TBI) over the next year. ...
(Date:8/20/2017)... ... 20, 2017 , ... A total solar eclipse will occur across the U.S. on ... moon moves between the sun and Earth. This rare event will be magnificent to witness, ... keep you safe on the road during the total eclipse of the sun. , 1. ...
(Date:8/20/2017)... ... August 20, 2017 , ... State Farm Neighborhood Assist® has named ... for a $25,000 grant. If the initiative wins, Gals Lead – Dream Queen Foundation’s ... the Tri-County area of St. Mary’s, Calvert and Charles Counties. The program could potentially ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... ... Ed Begley, Jr., will feature the Aurum Group in an upcoming episode, slated ... This segment of Innovations will feature the Aurum Group; a company committed to ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... CAESAREA, Israel , Aug. 11, 2017 ... company with mobile health and big data solutions, today ... results on Monday, August 14 and host a conference ... second quarter 2017 operating and financial results and its ... call will be hosted by Erez Raphael , ...
(Date:8/8/2017)...   Second-quarter 2017 revenues of ... share from continuing operations ... to $110 million Second-quarter ... million Second-quarter 2017 adjusted ... 8 percent to $0.93 ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: